Close menu




September 14th, 2022 | 13:24 CEST

Aspermont, Allkem, K+S - Shares for the fast lane

  • Digitization
  • Fintech
  • Lithium
Photo credits: pixabay.com

We are living in turbulent times on the stock markets. War, energy crisis and inflation are shaping the moods of market participants. Anticipatory action and understanding the "big picture" and the long-term correlations between supply and demand are part of a stock market trader's toolkit. Exaggerations and understatements are part of the package. There is no getting around shares as a long-term form of investment. Because as stock market veteran André Kostolany said, "If you want to eat well, buy stocks; if you want to sleep well, buy bonds."

time to read: 3 minutes | Author: Carsten Mainitz
ISIN: ASPERMONT LTD | AU000000ASP3 , Allkem Ltd. | AU0000193666 , K+S AG NA O.N. | DE000KSAG888

Table of contents:


    Aspermont - Many arrows in the quiver

    For 24 consecutive quarters, the media and FinTech house Aspermont from Perth, Australia, has recorded growth in its subscriber numbers. The digital transformation of the publisher of the oldest, continuously published mining magazines, Mining Journal (founded in 1835) and Mining Magazine (founded in 1909), can only be described as successful.

    The radical realignment towards a digital media and service house included digital B2B publications in the raw materials sector as the first step. The second pillar was the creation of a XaaS platform (Everything-as-a-Service), through which companies can book various services based on an extensive business database.

    Since this year, the Company has also successfully put its feelers out into the FinTech sector. With the launch of the financing platform "Blu Horseshoe" in cooperation with the Australian asset manager IPC and the Singalese roadshow specialist Spark Plus, qualified investors gain access to the market for placements on the Australian stock exchange ASX.

    In the first month after its launch, the platform processed an average of two transactions per day. And the potential is enormous: there are currently around 2,200 companies listed on the ASX, and about 120 new issues are made each year. Given these facts, the stock appears to be very lowly valued, with a market capitalization of around AUD 56 million. The analysts at GBC see the fair valuation as about 5 times as high.

    Allkem - Raw material prices set records

    The Australian Allkem Group, known as "Orocobre " until the merger with Galaxy Resources Ltd, is one of the big beneficiaries of the energy and transport revolution. Without lithium as a raw material, this would not be possible.

    Although there are now approaches to replacing lithium as a battery metal in the long term, leading experts agree that this will not be the case in the short or medium term. On the contrary, the German Federal Institute for Geosciences and Natural Resources (BGR) predicts a severe shortage of the raw material over the next 8 years (demand: up to 550,000 metric tons, maximum production from existing deposits: 358,000 metric tons).

    For Allkem, these are fantastic prospects. The Company is already reporting record profits. The Australians were able to report earnings of USD 337.2 million for the 2021/2022 financial year. The Company cited extensive cost management as the main reason, in addition to higher market prices.

    And Allkem continues to have ambitious goals: to triple production by 2026 and thus achieve a market share of around 10% in the global market. Currently, the Company ranks fifth among the world's largest lithium producers. The majority of analysts also rate the share as a buy. The experts at Crédit Suisse also expect Allkem to pay a dividend for the first time from 2023.

    K+S - Analysts expect the price to jump

    Kassel-based potash producer and fertilizer specialist K+S is one of the beneficiaries of Western sanctions against Russia. The limited supply and the further increase in demand caused the prices for potash salt to skyrocket. Despite sharply raised revenue and earnings forecasts, these good prospects have not been sufficiently reflected in the share price. Although the share price doubled between the end of January and April, it has now almost returned to its pre-war level.

    Analysts believe the stock has significant upside potential across the board. The experts at Warburg recently raised the price target from EUR 17 to EUR 30. The analysts at JPMorgan even believe the share has a price potential of EUR 44.50. On average, the consensus of 16 analysts is for a price target of around EUR 30 over the next 12 months.


    We live in turbulent times. In the long term, the fundamental key figures of companies almost always prevail. The fertilizer shortage will not be solved any time soon. Lithium will continue to grow in importance over the next few years. Digitization and access to financial markets will continue to advance. In terms of potential, Aspermont is certainly at the top of the trio.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Carsten Mainitz

    Carsten Mainitz

    The native Rhineland-Palatinate has been a passionate market participant for more than 25 years. After studying business administration in Mannheim, he worked as a journalist, in equity sales and many years in equity research.

    About the author



    Related comments:

    Commented by Jens Castner on October 21st, 2026 | 05:20 CEST

    Your Formula for Profits: What Are Bargains PayPal, Citigroup and Almonty Really Worth?

    • Formula
    • Benjamin Graham
    • Value investing
    • Undervaluation
    • Commodities
    • Tungsten
    • Defence
    • Banks
    • Fintech
    • Paypal
    • Citigroup
    • Almonty Industries
    • Fundamental analysis
    • Critical metals
    • Growth

    The US stock market is widely considered expensive, and bargains have become increasingly rare. Yet based on 2027 earnings estimates, some stocks still trade at a price-to-earnings (P/E) ratio of 10 or lower. Whether this alone constitutes a buy signal can be assessed using a formula developed by investing legend Benjamin Graham. It requires just a few inputs and accounts for what the P/E ratio alone overlooks: growth. Applied to companies such as PayPal, Citigroup and Almonty Industries, it produces some striking results — including the potential for substantial gains.

    Read

    Commented by Nico Popp on October 7th, 2026 | 09:15 CEST

    Aspermont, S&P Global and Alphabet: Specialized Data Poses a Challenge Even for Tech Giants

    • Digitization
    • bigdata
    • Technology
    • AI
    • Investments

    Generative artificial intelligence is fundamentally changing how information is obtained and siphoning organic web traffic away from traditional media platforms. As search engines utilize AI-generated answers, such as AI Overviews, the traditional advertising business of websites is losing its foundation. Publishers are becoming increasingly dependent on others, but specialized B2B information providers are carving out a lucrative niche. Deep industry knowledge built up over time still offers added value, as it is indispensable for reliable industrial applications and not easily replaceable. We shed light on this trend and highlight some exciting companies.

    Read

    Commented by Fabian Lorenz on October 7th, 2026 | 08:35 CEST

    Time to Sell Moderna Stock After a 200% Rally? A Comeback for Standard Lithium and HPQ Silicon?

    • Silicon
    • Batteries
    • FumedSilica
    • Lithium
    • Biotechnology
    • Drones

    Moderna's stock has had a spectacular run in recent weeks. Since mid-August, the biotech company's stock has surged from USD 63 to over USD 200. But now analysts are pouring cold water on the price surge. In their view, the stock could more than halve in value. While Moderna has already made a successful comeback, there are good reasons to believe that HPQ Silicon's is still to come. Despite positive news flow, the stock has yet to take off. Following successes in the drone sector, the company recently laid the groundwork to market its technology for producing fumed silica. Investors have been waiting for a comeback from Standard Lithium for quite some time. The stock is trading at a yearly low and approaching penny stock levels. Yet the company recently secured a new customer.

    Read